Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Overview | Financials
Company Name | Reviva Pharmaceuticals Holdings, Inc. |
Symbol | RVPH |
Currency | USD |
Price | 1.58 |
Market Cap | 73,595,136 |
Dividend Yield | 0% |
52-week-range | 0.6 - 4.83 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Laxminarayan Bhat Ph.D. |
Website | https://revivapharma.com |
An error occurred while fetching data.
About Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD